NOP53 and Alzheimer disease: The SVM-RFE method also selected some significant oncogenes, TPT1, GLTSCR2, GUSBP1, GDF1/LASS1 that were highly expressed, as opposed to MCAM that was found to have low expression levels in severe AD.